Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination
Latest in Blood
Plenary Papers
Marios Dimitriou; Teresa Mortera-Blanco; Magnus Tobiasson; Stefania Mazzi; Madeleine Lehander; Kari Högstrand; Mohsen Karimi; Gunilla Walldin; Monika Jansson; Sofie Vonlanthen; Per Ljungman; Saskia Langemeijer; Tetsuichi Yoshizato; Eva Hellström-Lindberg; Petter S. Woll; Sten Eirik W. Jacobsen
First Edition
Eve Blanquart; Rüçhan Ekren; Bineta Rigaud; Marie Veronique Joubert; virginie Baylot; Hélène Daunes; Marine Cuisinier; Marine Villard; Nadège Carrié; Celine Mazzotti; Liliana E Lucca; Aurore Perrot; Jill Corre; Thierry Walzer; Hervé Avet-Loiseau; Pierre-Paul Axisa; Ludovic Martinet
Clinical Trials and Observations
Jaime Sanz; Myriam Labopin; Goda Choi; Alexander Kulagin; Jacopo Peccatori; Jan Vydra; Péter Reményi; Jurjen Versluis; Montserrat Rovira; Didier Blaise; Hélène Labussière-Wallet; Juan Montoro; Simona Sica; Ellen Meijer; Maija Itälä-Remes; Nicolaas Schaap; Claude Eric Bulabois; Simona Piemontese; Mohamad Mohty; Fabio Ciceri

Advertisement intended for health care professionals




Featured Content

A biomarker for disease severity in Wiskott-Aldrich Syndrome; loss of Dnmt3a confers resistance to IFNα; unrelated donor selection in HSCT with PTCy

Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival

Loss of Dnmt3a increases self-renewal and resistance to pegIFN-α in JAK2V617F positive myeloproliferative neoplasms

Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT

Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume

An oral carbon monoxide–releasing molecule protects against acute hyperhemolysis in sickle cell disease

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals